PTU - Polskie Towarzystwo Urologiczne
list of articles:

THYROID HORMONES AT PATIENTS WITH SOME DISEASES OF THE BLADDER
Article published in Urologia Polska 1998/51/3.

authors

Zbigniew Tański, Adam Janiak
Oddział Urologiczny Wojewódzkiego Szpitala Zespolonego w Ostrołęce
Ordynator Oddziału: lek. med. E. Pogodski
Zakład Patomorfologii Wojewódzkiego Szpitala Zespolonego w Ostrołęce
Kierownik Zakładu: dr n. med. A. Janiak

keywords

bladder thyroid hormones low T3 syndrome

summary

Objective. The low T3 syndrome is often observed at patients with serious
chronic diseases. The aim of the study was the estimation of changes in serum
concentrations of the thyroid hormones at patients with genito-urinary tract
diseases.
Material and methods. The study was done at 33 patients: 7 women and 26
men. Among them were: 10 pts with cystolithiasis, 11 pts with bladder
carcinoma, 1 pts with bladder papilloma, 11 pts with cystitis. In all patients
following examinations were done: ultrasonography of the abdomen, IVP
biochemical examinations: serum concentration of T3,T4 creatinine, BUN,
proteinogram. EIA-ABBOT method was used to estimate T3 and T4 serum
concentrations.
Results. The following results of serum T3 concentrations were observed: at
bladder stone patients from 1.0 to 2.6 nmol/1, medium 1.71 ? 0.4 nmol/1, at
bladder cancer patients from 1.0 to 2.0 nmol/1, medium 1.6 ? 0.3 nmol/1, at
patients with cystitis from 1.2 to 3.0 nmol/1, medium 1.7 ? 0.5 nmol/1. The
serum concentrations of creatinine and proteins were normal.
Conclusions. The low T3 syndrome was not observed at patients with genito-
urinary tract diseases such as bladder stone diseases, cystitis and bladder
carcinoma. At 8 pts after surgical treatment without complications the serum
T3 concentrations were normal too. At 3 patients with serum T3 postoperative
infection the serum T3 concentrations were significantly lowered.

references

  1. [1] Ceremużyński, L.: Hormonal and metabolic reactions evoked by acute myocar-
  2. dial infarction. Circ. Res. 1981, 48, 767-770.
  3. [2] Dutkiewicz, S., Kałczak, M.: Quantitative-comparative histology of prostatic
  4. adenomas in medically and surgically treated patients. Int. Urol. Nephrol. 1994, 26,
  5. 1-5.
  6. [3] Epstein, F. H.: The molecular basis of thyroid hormone action. Br. Med. J. 1994,
  7. 331, 847-851.
  8. [4] Holland, F. W. i wsp.: Cardiopulmonary Bypass and Thyroid Function: A Eu-
  9. thyroid Sick Syndrome. Soc. Thor. Surg. 1991, 46-49.
  10. [5] Kohrle, J.: Thyroid hormone deiodination in target tissues - a regulator role for
  11. the tracę element selenium? Exp. Clin. Endocrinol. 1994,102, 63-66.
  12. [6] Kohrle, J. i wsp.: Type 15'-deiodinase - a marker for differentiated thyroid car-
  13. cinoma? Exp. Clin. Endocrinol. 1993,101, 60-64.
  14. [7] Koller, J. i wsp.: Thyroid hormones and their impact on the hemodynamic and
  15. metabolic stability of organ donors and on kidnay graft function after transplanta-
  16. tion. Transplant. Proc. 1990, 22, 355-359.
  17. [8] Lee, P. C. i wsp.: Thyroid hormone responses in the early kidney transplants.
  18. Transplant. Proc. 1994, 26, 2184-2191.
  19. [9] Nauman, A.: Tarczyca i mechanizmy regulujące wydzielanie aktywnego hormo-
  20. nu. Endokrynol. Pol. 1993, 44,109-112.
  21. [10] Nauman, A. i w sp.: Aktywność T4 5'-dejodynazy w raku jasnokomórkowym nerki.
  22. Dzień Urologiczny Polskiego Towarzystwa Urologicznego, Łódź, 27 wrze-
  23. śnia 1991. Pamiętnik PTU 1991, 5-9.
  24. [11] Nauman, A. i wsp.: Serum thyroid hormones concentrations in patients with
  25. kidney cancer before and after unilateral nephrectomy. Eur. J. Endocrinol. 1995,5,
  26. 2-6.
  27. [12] Silva, J. J. E. i wsp.: Evidence for two tissues - specific pathways for in vivo
  28. thyroxin 5'-deiodination in the rat. J. Clin. Invest. 1982, 69,1176-1179.
  29. [13] Vaziri, N. D.: Endocrinological conseąuences of the nephrotic syndrome. Am. J.
  30. Nephrol. 1993,13, 360-364.
  31. [14] Wartof sky, L.: The low T3or sick euthyroid syndrome: update 1994. Endocr. Soc.
  32. 1994, 3, 248-252.